About 100 Mg -Vial Bendamustine Hydrochloride Injection
Unlock the efficacy of anti-cancer therapy with the classic 100 mg-Vial Bendamustine Hydrochloride Injection. Procure this masterpiece of precision treatment for Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma-crafted as a highly polished, lyophilized powder that transforms into a fresh, clear-to-slightly-yellowish solution upon reconstitution. Housed in a secure glass vial with rubber stopper, this product meets USP standards and offers maximum purity. Each dose ensures high therapeutic value and is compatible with 0.9% sodium chloride, reflecting a standard of excellence for oncology care professionals.
Key Competitive Advantages & Usage
100 mg-Vial Bendamustine Hydrochloride Injection is a premium lyophilized formulation, crafted to deliver high purity and consistent results in anti-cancer therapy. Its single-use vial design ensures optimal sterility, while flexible dilution compatibility allows seamless integration into standard clinical protocols. With masterful USP compliance and versatile application for both Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma, this product stands out for its ease of use, trusted therapeutic class, and polished handling features.
Certifications, Packaging & Delivery Details
Delivered under strict regulatory standards and USP compliance, the 100 mg-Vial Bendamustine Hydrochloride Injection is handed over in premium-grade glass vials, sealed with rubber stoppers to safeguard product integrity. It features a secure packaging profile tailored for export, distributor, and supplier needs. Packaging details are optimized for safety during transport, with a 24-month shelf life, and the product is available for shipment from India's leading FOB ports, ensuring timely and protected delivery.
FAQ's of 100 Mg -Vial Bendamustine Hydrochloride Injection:
Q: How should 100 mg-Vial Bendamustine Hydrochloride Injection be administered?
A: It is meant for intravenous administration only, following reconstitution with sterile water and dilution with 0.9% sodium chloride as indicated by your healthcare provider.
Q: What conditions can this injection treat?
A: This medication is primarily indicated for the treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma as part of anti-cancer therapy.
Q: When should the injection be used after reconstitution?
A: For optimal efficacy and safety, use the reconstituted solution as soon as possible, following your hospital's or physician's guidelines regarding storage and administration timelines.
Q: Where is the 100 mg-Vial Bendamustine Hydrochloride Injection manufactured and supplied from?
A: It is distributed, exported, and supplied from India by multiple certified manufacturers and specialist traders adhering to USP standards.
Q: What are the special features of this product?
A: Key features include high purity, a lyophilized powder form, premium glass vial with rubber stopper, single-use design, and compatibility with standard intravenous fluids.
Q: How does Bendamustine Hydrochloride work in the body?
A: It acts as an alkylating agent, damaging the DNA of malignant cells and inducing apoptosis, thus disrupting cancer cell proliferation.
Q: What precautions should be taken when handling this medication?
A: As a cytotoxic drug, it should be handled with care, using protective equipment to prevent exposure, and should be stored below 25C and protected from light.